Medios AG (FRA:ILM1) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ILM1 Medios AG FRA:ILM1
88 GF Score
Price €12.10
GF Value €17.16
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medios AG Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:ILM1
88GF Score
Medios AG FRA:ILM1
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medios AG (FRA:ILM1) Overvalued in 2026?

Based on GuruFocus' analysis, Medios AG stock appears to be undervalued. The current stock price of €12.10 is trading 29.5% below its estimated GF Value™ of €17.16. GuruFocus considers Medios AG to be Modestly Undervalued.

Key valuation signals for FRA:ILM1:

  • Dividends Received:
  • GF Value™: €17.16 vs. price of €12.10 (29.5% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the FRA:ILM1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medios AG Business Description

Address Heidestrasse 9, Berlin, DEU, 10557
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score

Get the complete analysis for FRA:ILM1

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.10
Price
€17.16
GF Value